Dicloxacillin is a narrow-spectrum β-lactam antibiotic of the penicillin class. It is used to treat infections caused by susceptible (non-resistant) Gram-positive bacteria. It is active against beta-lactamase-producing organisms such as Staphylococcus aureus, which would otherwise be resistant to most penicillins. Dicloxacillin is available under a variety of trade names including Diclocil (BMS).
It was patented in 1961 and approved for medical use in 1968. It is available as a generic medication.
Dicloxacillin is used to treat mild-to-moderate staphylococcal infections. To decrease the development of resistance, dicloxacillin is recommended to treat infections that are suspected or proven to be caused by beta-lactamase-producing bacteria.
Dicloxacillin is similar in pharmacokinetics, antibacterial activity, and indications to flucloxacillin, and the two agents are considered interchangeable. It is believed to have lower incidence of severe hepatic adverse effects than flucloxacillin, but a higher incidence of renal adverse effects.
Dicloxacillin is used for the treatment of infections caused by susceptible bacteria. Specific approved indications include:
Staphylococcal skin infections and cellulitis – including impetigo, otitis externa, folliculitis, boils, carbuncles, and mastitis
Pneumonia (adjunct)
Osteomyelitis, septic arthritis, throat infections, streptococcus
Septicaemia
Empirical treatment for endocarditis
Surgical prophylaxis
Dicloxacillin is commercially available as the sodium salt, dicloxacillin sodium, in capsules and as a powder for reconstitution.
Dicloxacillin is contraindicated in those with a previous history of allergy (hypersensitivity/anaphylactic reaction) to any penicillins.
Common adverse drug reactions (ADRs) associated with the use of dicloxacillin include: diarrhea, nausea, rash, urticaria, pain and inflammation at injection site, superinfection (including candidiasis), allergy, and transient increases in liver enzymes and bilirubin.
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.
La flucloxacilline est un composé organique antibiotique bêta-lactamine de spectre étroit, de la classe des pénicillines. Sa principale fonction est de traiter les infections causées par des bactéries Gram-positives sensibles et le Staphylococcus aureus stable c'est-à-dire sensible à l'oxacilline. En effet, elle est fréquemment utilisée pour prévenir et guérir les infections du nez et de la gorge, telles que les pneumonies et les amygdalites.
Methicillin (USAN), also known as meticillin (INN), is a narrow-spectrum β-lactam antibiotic of the penicillin class. Methicillin was discovered in 1960. Compared to other penicillins that face antimicrobial resistance due to β-lactamase, it is less active, can be administered only parenterally, and has a higher frequency of interstitial nephritis, an otherwise-rare adverse effect of penicillins. However, selection of methicillin depended on the outcome of susceptibility testing of the sampled infection, and since it is no longer produced, it is also not routinely tested for any more.
Le furoncle est une infection bactérienne profonde d'un follicule pileux provoquant la nécrose périfolliculaire et la suppuration. Il en résulte une induration douloureuse du derme causée par une accumulation de pus et de tissus morts. Au terme de sa maturation, entre 5 et 10 jours, le furoncle s'ouvre et élimine le follicule pileux (bourbillon) formant une ulcération cratériforme. La guérison survient en quelques jours laissant une cicatrice atrophique.
In addition to the general aims of lightning research such as lightning physics and meteorology, the study of upward lightning is of particular importance in protection of tall objects such as wind turbines and telecommunication towers. It also helps us in ...
Bicyclic peptide ligands are promising molecules for the development of new therapeutics. They combine advantages from large protein therapeutics and small molecule drugs. Large combinatorial libraries of bicyclic peptides can be generated and screened by ...
EPFL2014
,
To provide new insights toward the selection of the most suitable AOP for isoxazolyl penicillins elimination, the degradation of dicloxacillin, a isoxazolyl penicillin model, was studied using different advanced oxidation processes (AOPs): ultrasound (US), ...